comparemela.com

Latest Breaking News On - Oncology institute inc - Page 9 : comparemela.com

The Oncology Institute, Inc (NASDAQ:TOI) Director Sells $56,000 00 in Stock

The Oncology Institute, Inc. (NASDAQ:TOI – Get Free Report) Director Brad Hively sold 25,000 shares of the business’s stock in a transaction that occurred on Friday, November 17th. The stock was sold at an average price of $2.24, for a total transaction of $56,000.00. Following the sale, the director now directly owns 697,065 shares in […]

Brookdale Senior Living: Upside Remains Limited Due To Balance-Sheet Concerns (NYSE:BKD)

Brookdale Senior Living: Upside Remains Limited Due To Balance-Sheet Concerns (NYSE:BKD)
seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.

The Oncology Institute Reports Third Quarter 2023 Financial Results and Reaffirms Full Year 2023 Guidance

CERRITOS, Calif., Nov. 08, 2023 The Oncology Institute, Inc. , one of the largest value-based community oncology groups in the United States, today reported financial results for its three and.

The Oncology Institute Reports Third Quarter 2023 Financial Results and Reaffirms Full Year 2023 Guidance

The Oncology Institute Reports Third Quarter 2023 Financial Results and Reaffirms Full Year 2023 Guidance
businessinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from businessinsider.com Daily Mail and Mail on Sunday newspapers.

Reviewing ETAO International (NASDAQ:ETAO) & Oncology Institute (NASDAQ:TOI)

Oncology Institute (NASDAQ:TOI – Get Free Report) and ETAO International (NASDAQ:ETAO – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, earnings, valuation, analyst recommendations, dividends, risk and institutional ownership. Institutional and Insider Ownership 23.5% of Oncology […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.